Rezultati
eNauka >
Results >
Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment
| Title: | Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment | Authors: | Milašinović, Bojana; Marković, Srđan |
Issue Date: | 2026 | Publication: | Pharmaceuticals | ISSN: | 1424-8247 Pharmaceuticals Search Idenfier |
Publisher: | Basel, Switzerland : MDPI | Type: | Article | Collation: | vol. 19 br. 8 str. 1239 | DOI: | 10.3390/ph19081239 | WoS-ID: | 001858881300001 | PMID: | 42653736 | PMCID: | PMC13516148 | URI: | https://farfar.pharmacy.bg.ac.rs/handle/123456789/6552 https://enauka.gov.rs/handle/123456789/1050274 |
URL: | https://www.mdpi.com/1424-8247/19/8/1239 | Project: | optYmAb - Improving Clinical Outcomes with Precision Dosing in Patients with Inflammatory Bowel Disease Through Investigating Variability of Monoclonal Antibodies Based on Population Pharmacokinetic-Pharmacodynamic Modeling | M-category: | 21aM21a |